The wiki’s first whole-dietary-PATTERN RCT with hard endpoints. Everything else in the cardiometabolic cluster is a single nutrient (SFA, sugar, sodium) or a weight-loss trial; PREDIMED (Estruch 2018) tests a pattern — Mediterranean diet vs a low-fat control — against events, not a surrogate. It is the source that lets the fabric say something about patterns-vs-nutrients, and its result is genuinely informative in both directions.
The headline: a pattern cut CV events ~30%, at high baseline risk — but read the components
In 7447 high-CV-risk adults with no CVD at baseline (Spain, median 4.8 yr), a Mediterranean diet supplemented with extra-virgin olive oil or nuts, vs advice to reduce fat, cut the primary composite (MI + stroke + CV death):
- Combined MedDiet primary composite HR 0.70 (0.55-0.89) — «a relative difference of 30% and an absolute difference of 1.7 to 2.1 percentage points» over 5 yr (5-yr absolute risk 3.8% vs 5.7%). [EXTRACTED (Estruch - PREDIMED Mediterranean Diet 2018) chunk 01]
- The composite is carried by STROKE — HR 0.58 (0.42-0.82). MI (0.80) and CV death (0.80) are individually non-significant, and all-cause mortality is NULL — 0.98 (0.77-1.24). So the honest claim is the pattern reduced (mostly) stroke events in high-risk primary prevention over ~5 years; it did not measurably move total mortality in that window. The trial was underpowered for the components (lower-than-expected event rates).
- Adherence mattered: the per-protocol (adherence-adjusted) primary HR was 0.42 (0.24-0.63).
Why this matters at the pattern level — three decision-relevant reads
- The pattern worked WITHOUT weight loss or exercise. The diet was «energy-unrestricted» and
physical activity was not promoted; there was little between-group weight change. So a composition
change — not calorie restriction, not weight loss — moved events. This is the striking complement to
Does Weight Loss Reduce Cardiovascular Events: lifestyle weight loss did not cut CV events
(Look AHEAD null; the 54-RCT meta-analysis null on events), yet a dietary pattern did. The lever
for CV events here is what you eat, not how much you weigh.
[INFERRED (Estruch - PREDIMED Mediterranean Diet 2018) from the energy-unrestricted design + the null weight-loss channel; the cross-trial contrast is reasoned, populations differ — see the parameter table below] - High baseline risk is why the absolute benefit is real. These were high-risk adults (~49% T2D, ~82% hypertensive); absolute benefit scales with baseline risk (Baseline Risk and the Relative-Absolute Split). Author-stated: «whether the results can be generalized to persons at lower risk requires further research.» So this REFINES Cardiometabolic Interventions and Hard CV Outcomes in Low-Risk People rather than overturning it — a pattern intervention buys hard-outcome benefit where baseline risk is high; it says nothing about the low-risk person, where the ceiling argument still binds.
- The contrast was a small pattern shift, not diet-vs-junk. Most participants ate near-Mediterranean at baseline and the control got healthy-diet advice; the largest between-group differences were in fat subtypes (the supplied EVOO and nuts) plus more fish and legumes. That the 30% came from a modest shift over an already-decent diet cuts both ways — impressive per unit change, but not a licence to expect the same from adding EVOO to a poor diet.
The fat-quality channel — corroborates the SFA replacement story on HARD outcomes
The intervention’s active contrast was largely a shift toward unsaturated fat (EVOO, nuts) — the
same replacement Saturated Fat Intake and Replacement argues for on LDL/apoB and events. PREDIMED
adds the whole-pattern, hard-outcome version of that channel: a mono/polyunsaturated-rich pattern cut
events. [E-independent] is NOT claimed — the mechanism overlaps the SFA-replacement channel rather
than arriving from a separate route, so this is refinement/consistency, not independent backing.
The provenance caveat travels with the estimate (symmetric standards)
PREDIMED’s 2013 report was withdrawn (Carlisle 2017 flagged non-random baseline distributions);
the 2018 re-analysis found real irregularities — 425 household members assigned without randomization,
one site assigned by clinic, inconsistent tables at another — and re-estimated with propensity scores
over 30 covariates, «methods that do not rely exclusively on the assumption that all the participants
had been randomly assigned». Results held across sensitivity analyses (excluding the 1588 deviating
participants — Sites D+B + second household members, n=5859: combined HR 0.69 (0.53-0.92)). Internal
validity is therefore RCT-with-propensity-repair, not a
clean randomized contrast — a real, quantified discount that a favourable result does not earn
exemption from. Held here as a medium-confidence finding for that reason.
Parameter table — the pattern-vs-weight-loss contrast (BLOCKING cross-source check)
| Parameter | PREDIMED (this) | Look AHEAD / Ma (Does Weight Loss Reduce Cardiovascular Events) | Same quantity? |
|---|---|---|---|
| Intervention | MedDiet pattern (EVOO/nuts), energy-unrestricted | Intensive lifestyle for weight loss (calorie deficit + PA) | No — different lever (composition vs energy/weight) |
| Population | High-risk primary prevention (no CVD; ~49% T2D) | Look AHEAD: established T2D; Ma: obese adults | Overlapping, not identical |
| Primary outcome | MI + stroke + CV death | CV composite (similar) | Yes (CV event composite) |
| Result on CV events | HR 0.70 (0.55-0.89) | Null (Look AHEAD ~0.95; Ma null on events) | Comparable outcome, opposite result |
| Weight change | Minimal (energy-unrestricted) | Substantial (the intervention’s target) | — |
Defensible claim from the table: for CV events, the dietary-pattern/composition channel and the weight-loss channel are distinct, and here the pattern channel delivered where weight loss did not — with the caveat that the populations and comparators differ, so this is a reasoned cross-trial contrast (type-A synthesis), not a head-to-head.
Limits
- Single trial,
confidence: medium— one landmark RCT, and one carrying an internal-validity discount (the reanalysis). The observational + Lyon-secondary-prevention consistency the paper cites is within-source and same-diet-hypothesis, so it is not independent (type-E) backing; a second independent pattern-RCT would raise confidence. - Stroke-specific, mortality-null over 4.8 yr — do not read the composite as a mortality claim.
- High-risk, Mediterranean-baseline population — transportability to low-risk or non-Mediterranean eaters is the open question the authors themselves flag.
- Not a component-isolation trial — it cannot say whether EVOO, nuts, fish, or the whole gestalt did the work (the observed-healthy-pattern-is-not-evidence-for-a-component caveat applies).
Self-critique [run 2026-07-29, before commit]
- Over-claim check: the composite 0.70 is not read as a mortality or MI claim — the stroke-driven
decomposition and the null all-cause HR are stated up front; the “pattern beats weight loss” claim is
tagged
[INFERRED]and gated behind a parameter table naming the population/comparator differences, not asserted as head-to-head. - Laundered-E avoided: the SFA-replacement overlap is explicitly called refinement/consistency, NOT
[E-independent], because the mechanism is shared, not a separate route; the within-source observational corroboration is flagged as non-independent. - Symmetric standards: the retraction/reanalysis discount is applied to a favourable result — the exact case where motivated reasoning would wave it through.